» Articles » PMID: 33371312

Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Dec 29
PMID 33371312
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Besides their role in hemostasis and thrombosis, it has become increasingly clear that platelets are also involved in many other pathological processes of the vascular system, such as atherosclerotic plaque formation. Atherosclerosis is a chronic vascular inflammatory disease, which preferentially develops at sites under disturbed blood flow with low speeds and chaotic directions. Hyperglycemia, hyperlipidemia, and hypertension are all risk factors for atherosclerosis. When the vascular microenvironment changes, platelets can respond quickly to interact with endothelial cells and leukocytes, participating in atherosclerosis. This review discusses the important roles of platelets in the plaque formation under pro-atherogenic factors. Specifically, we discussed the platelet behaviors under disturbed flow, hyperglycemia, and hyperlipidemia conditions. We also summarized the molecular mechanisms involved in vascular inflammation during atherogenesis based on platelet receptors and secretion of inflammatory factors. Finally, we highlighted the studies of platelet migration in atherogenesis. In general, we elaborated an atherogenic role of platelets and the aspects that should be further studied in the future.

Citing Articles

Antiplatelet Effects of a Combination of Sappan Wood ( L.) and Red Ginger () Extracts in a High-Fat Diet-Induced Rat Model.

Puteri M, Afifah N, Mathriul A, Wicaksono F, Sugiarti M, Izzatinisa R Adv Pharmacol Pharm Sci. 2024; 2024:5543717.

PMID: 39734397 PMC: 11679274. DOI: 10.1155/adpp/5543717.


Systemic inflammatory index as a predictive marker for the severity of coronary artery disease in individuals with chronic kidney disease.

Zhao M, Zhang Y, Huang X, Peng J J Geriatr Cardiol. 2024; 21(10):962-971.

PMID: 39619363 PMC: 11605509. DOI: 10.26599/1671-5411.2024.10.002.


CYP2C19 Poor Metabolizer Status and High System Inflammation Response Index are Independent Risk Factors for Premature Myocardial Infarction: A Hospital-Based Retrospective Study.

Han W, Xiong N, Zhong R, Pan Z Int J Gen Med. 2024; 17:4959-4969.

PMID: 39494358 PMC: 11529344. DOI: 10.2147/IJGM.S489235.


Cryo-EM structures of the human P2X1 receptor reveal subtype-specific architecture and antagonism by supramolecular ligand-binding.

Oken A, Lisi N, Ditter I, Shi H, Nechiporuk N, Mansoor S Nat Commun. 2024; 15(1):8490.

PMID: 39353889 PMC: 11448502. DOI: 10.1038/s41467-024-52636-4.


Novel Therapeutics for Type 2 Diabetes Mellitus-A Look at the Past Decade and a Glimpse into the Future.

Chee Y, Dalan R Biomedicines. 2024; 12(7).

PMID: 39061960 PMC: 11274090. DOI: 10.3390/biomedicines12071386.


References
1.
Martorell L, Martinez-Gonzalez J, Rodriguez C, Gentile M, Calvayrac O, Badimon L . Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost. 2008; 99(2):305-15. DOI: 10.1160/TH07-08-0481. View

2.
Coenen D, Mastenbroek T, Cosemans J . Platelet interaction with activated endothelium: mechanistic insights from microfluidics. Blood. 2017; 130(26):2819-2828. DOI: 10.1182/blood-2017-04-780825. View

3.
Zimman A, Titz B, Komisopoulou E, Biswas S, Graeber T, Podrez E . Phosphoproteomic analysis of platelets activated by pro-thrombotic oxidized phospholipids and thrombin. PLoS One. 2014; 9(1):e84488. PMC: 3882224. DOI: 10.1371/journal.pone.0084488. View

4.
Koenen R, von Hundelshausen P, Nesmelova I, Zernecke A, Liehn E, Sarabi A . Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med. 2009; 15(1):97-103. DOI: 10.1038/nm.1898. View

5.
Jamasbi J, Megens R, Bianchini M, Uhland K, Munch G, Ungerer M . Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation. JACC Basic Transl Sci. 2016; 1(3):131-142.. PMC: 5063538. DOI: 10.1016/j.jacbts.2016.03.008. View